TP317, a first-in-class resolvin E1 small molecule, potentiates the efficacy of immune checkpoint (ICI) inhibitors in ICI-resistant and ICI-sensitive tumors-MedSci.cn

TP317, a first-in-class resolvin E1 small molecule, potentiates the efficacy of immune checkpoint (ICI) inhibitors in ICI-resistant and ICI-sensitive tumors

Kipper, FC; Rothenberger, E; Kelly, A; Gillespie, M; Attaya, A; Bielenberg, DR; Huang, S; Pflieger, L; Sciavolino, F; Mathias, A; Klohs, W; Parkinson, J; Mathias, G; Panigrahy, D

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务